Showing results (1-10 of 303) with videos related to
Sort By:
Pageof 31
Therapie|February 10, 2000
[How to improve drug development and utilization in pediatrics]G Pons, C Lassale, E EschwegeTherapie|November 9, 2002
[Methodology and long-term follow-up of drug induced side effects in children (cancer, leukemia, AIDS, growth hormone)]N Hoog-Labouret, C Lassale, E Eschwege, et al.Diabete & Metabolisme|October 1, 1995
Risk factors and their identification. Third Part: ExamplesB Balkau, E EschwegeJournal of Perinatal Medicine|January 1, 1976
Estrogens, lactation and oral glucose tolerance test in the early puerperiumD Job, E EschwegeDiabete & Metabolisme|June 1, 1995
Risk factors and their identification second part: study designs for identification of risk factorsB Balkau, E EschwegeDiabete & Metabolisme|July 1, 1987
Diabetes, hyperglycaemia, hyperinsulinaemia and atherosclerosis: epidemiological dataA Fontbonne, E EschwegeDiabete & Metabolisme|February 1, 1995
Risk factors and their identification. First Part: What is a risk factor?B Balkau, E EschwegeBritish Journal of Clinical Pharmacology|October 1, 1994
Stereoselective disposition of ibuprofen enantiomers in infantsE Rey, A Pariente-Khayat, L Gouyet, et al.Therapie|October 27, 2001
[Drug effects in elderly subjects: from the pharmacologic target to the risk-benefit. Round Table #5 of the 16th National Clinical Pharmacology Workshop]C Lassale, F Piette, P JollietRevue D'Epidemiologie Et De Sante Publique|January 1, 1986
Drug sales data and prevalence of diabetes in FranceA Fontbonne, L Papoz, E EschwegePageof 31